JEFFREY D CAPELLO
CIK 1224108 · EVP & Chief Financial Officer · last filed 2025-10-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.10M
Companies
7
Total Filings
64
Lifetime Open-Market Net
-$13.49M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NEOG | Director | 32,502 | $9.10 | $295.8K | $100.2K | 10 | 2025-10-29 |
| AGIO | Director | 6,073 | $29.46 | $178.9K | $0 | 5 | 2025-06-23 |
| BIIB | EVP & Chief Financial Officer | 3,118 | $200.05 | $623.8K | $0 | 5 | 2020-02-14 |
| Tempest Therapeutics, Inc. (OVAS) Delisted | Director | — | — | — | $0 | 5 | 2018-07-06 |
| Salarius Pharmaceuticals, Inc. (FLKS) Delisted | Director | — | — | — | $0 | 3 | 2017-07-27 |
| BOSTON SCIENTIFIC CORP (BSXw) Delisted | EVP & Chief Financial Officer | 447 | — | — | -$12.60M | 30 | 2013-12-02 |
| REVVITY, INC. (PKI) Delisted | SVP & CFO | 91,428 | $115.24 | $10.54M | -$989.9K | 4 | 2008-01-31 |
Recent Filings · Page 2 of 7
64 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-24 | AGIO | Grant (A) | — | $0 | EDGAR |
| 2024-06-17 | AGIO | Exer (M) | +1,976 | $0 | EDGAR |
| 2023-10-31 | NEOG | Exer (M) | — | $0 | EDGAR |
| 2023-06-15 | AGIO | Grant (A) | — | $0 | EDGAR |
| 2022-10-11 | NEOG | Exer (M) | — | $0 | EDGAR |
| 2020-02-14 | BIIB | Mixed | +1,305 | -$203.7K | EDGAR |
| 2020-01-06 | BIIB | Mixed | +896 | -$119.4K | EDGAR |
| 2019-02-14 | BIIB | Grant (A) | — | $0 | EDGAR |
| 2019-01-04 | BIIB | Mixed | +917 | -$126.1K | EDGAR |
| 2018-07-06 | Tempest Therapeutics, Inc. (OVAS) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.